Table 1.

The demographic and clinical features of Takayasu arteritis patients during the time of imaging.

Sex, (female/male)	28/6
Age, years, mean ± SD	40.5 ± 15.1
Disease duration, years, mean ± SD	9.3 ± 6.5
Cardiovascular risk factors
Diabetes, n (%)	2 (6)
Hypertension, n (%)	15 (46)
Hyperlipidemia, n (%)	9 (27)
Smoking-ever, n (%)	11 (33)
BMI, kg/m 2 , mean ± SD	23.0 ± 3.6
Immunosuppressives n (%)	35 (76)
Azathioprine	18 (39)
Methotrexate	6 (13)
Leflunomide	9 (20)
TNF-α inhibitors	4 (9)
Glucocorticoid use present, n (%)	29 (63)
Glucocorticoid dose, mg†, median (range)	5 (2.5–80)
Acute phase reactants
ESR, mm/h, mean ± SD	49.1 ± 28.0
CRP, mg/L, median (range)	16.3 (2–126)

^†Prednisolone equivalent dose